Time is running out… Oracle emerges as the apparent winner for TikTok’s U.S. assets as CNBC learns that ByteDance hopes a “technology partnership” with the American software giant will stave off sanctions. This, after the Chinese group rejected a full-sale offer from Microsoft. Softbank shares surge after agreeing to sell chip designer Arm to Nvidia for $40bn. There are reports the Japanese investor is looking to go private. U.S. biotech firm Gilead is acquiring cancer treatment developer Immunomedics for $21bn as it continues work on its Covid treatment drug Remdesivir. And in the UK, AstraZeneca is restarting trials for its Coronavirus vaccine candidate after last week’s pause over safety concerns, while rivals Pfizer and Biontech expand the scope of their late-stage testing.   

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.